Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals - Paterson, R W; Bartlett, J W; Blennow, K; Fox, N C; Shaw, L M; Trojanowski, J Q; Zetterberg, H; Schott, J M (Translational psychiatry, 2014)
Keywords: 631/378/1689/364; 692/53; 692/699/375/132/1283; Aged; Aged, 80 and over; Alzheimer Disease - cerebrospinal fluid; Alzheimer Disease - pathology; Amyloidosis - cerebrospinal fluid; Amyloidosis - pathology; Apolipoprotein E4 - cerebrospinal fluid; Atrophy; Behavioral Sciences; BETA; Biological Psychology; BIOMARKERS; Biomarkers - cerebrospinal fluid; Brain - pathology; BRAIN ATROPHY; CEREBRAL ATROPHY; Cerebral Ventricles - pathology; Cognitive Dysfunction - cerebrospinal fluid; Cognitive Dysfunction - pathology; Cystatin C - cerebrospinal fluid; Female; Hippocampus - pathology; Humans; INCIPIENT ALZHEIMERS-DISEASE; Male; Medicine & Public Health; Mental Status Schedule; MILD COGNITIVE IMPAIRMENT; MRI; NEUROPEPTIDE; Neurosciences; Neurovetenskaper; Original; original-article; Peptides - cerebrospinal fluid; Pharmacotherapy; Psychiatry; RATES; Statistics as Topic; tau Proteins - cerebrospinal fluid; Trefoil Factor-3